相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Well Infant With Coronavirus Disease 2019 With High Viral Load
Kai-Qian Kam et al.
CLINICAL INFECTIOUS DISEASES (2020)
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
Qiurong Ruan et al.
INTENSIVE CARE MEDICINE (2020)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options
Tomasz J. Guzik et al.
CARDIOVASCULAR RESEARCH (2020)
Obesity Is a Risk Factor for Severe COVID-19 Infection Multiple Potential Mechanisms
Naveed Sattar et al.
CIRCULATION (2020)
Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19
Peng Zhang et al.
CIRCULATION RESEARCH (2020)
Inflamm-aging: Why older men are the most susceptible to SARS-CoV-2 complicated outcomes
Massimiliano Bonafe et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2020)
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
Wei-jie Guan et al.
EUROPEAN RESPIRATORY JOURNAL (2020)
Effects of Angiotensin II Receptor Blockers and ACE (Angiotensin-Converting Enzyme) Inhibitors on Virus Infection, Inflammatory Status, and Clinical Outcomes in Patients With COVID-19 and Hypertension A Single-Center Retrospective Study
Guang Yang et al.
HYPERTENSION (2020)
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy
Giacomo Grasselli et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
COVID-19 illness in native and immunosuppressed states: A clinical?therapeutic staging proposal
Hasan K. Siddiqi et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2020)
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis
Zhaohai Zheng et al.
JOURNAL OF INFECTION (2020)
COVID-19 spike-host cell receptor GRP78 binding site prediction
Ibrahim M. Ibrahim et al.
JOURNAL OF INFECTION (2020)
In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs
Abhigyan Choudhury et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
COVID-19 and Older Adult
John E. Morley et al.
JOURNAL OF NUTRITION HEALTH & AGING (2020)
COVID-19 and Older Adults: What We Know
Zainab Shahid et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes
Janko Nikolich-Zugich et al.
GEROSCIENCE (2020)
The Role of Adipocytes and Adipocyte-Like Cells in the Severity of COVID-19 Infections
Ilja L. Kruglikov et al.
OBESITY (2020)
Obesity and COVID-19: An Italian Snapshot
Luca Busetto et al.
OBESITY (2020)
Is Adipose Tissue a Reservoir for Viral Spread, Immune Activation, and Cytokine Amplification in Coronavirus Disease 2019?
Paul MacDaragh Ryan et al.
OBESITY (2020)
Risk of COVID-19 for patients with obesity
Radwan Kassir
OBESITY REVIEWS (2020)
Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis
Brandon Michael Henry et al.
CLINICA CHIMICA ACTA (2020)
COVID-19 in people with diabetes: understanding the reasons for worse outcomes
Matteo Apicella et al.
LANCET DIABETES & ENDOCRINOLOGY (2020)
Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit
Geehan Suleyman et al.
JAMA NETWORK OPEN (2020)
Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts
Jin Wang et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2020)
COVID-19: lessons to date from China
Xiaoxia Lu et al.
ARCHIVES OF DISEASE IN CHILDHOOD (2020)
SARS-CoV-2 infection and obesity: Common inflammatory and metabolic aspects
Konstantinos Michalakis et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
COVID-19 and diabetes mellitus: An unholy interaction of two pandemics
Rimesh Pal et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2020)
Down Syndrome and COVID-19: A Perfect Storm?
Joaquin M. Espinosa
CELL REPORTS MEDICINE (2020)
Interleukin 6 trans-signalling and risk of future cardiovascular events
Louise Ziegler et al.
CARDIOVASCULAR RESEARCH (2019)
Tannic acid protects against experimental acute lung injury through downregulation of TLR4 and MAPK
Ayyanar Sivanantham et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
PAR2-Mediated cAMP Generation Suppresses TRPV4-Dependent Ca2+ Signaling in Alveolar Macrophages to Resolve TLR4-Induced Inflammation
Sheikh Rayees et al.
CELL REPORTS (2019)
Modulation of Nitric Oxide Synthases by Oxidized LDLs: Role in Vascular Inflammation and Atherosclerosis Development
Micaela Gliozzi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Immunobiology of Atherosclerosis: A Complex Net of Interactions
Beatriz Herrero-Fernandez et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Relevance of Leptin and Other Adipokines in Obesity-Associated Cardiovascular Risk
Manuel F. Landecho et al.
NUTRIENTS (2019)
Aging leads to dysfunctional innate immune responses to TLR2 and TLR4 agonists
Kristina L. Bailey et al.
AGING CLINICAL AND EXPERIMENTAL RESEARCH (2019)
MicroRNA-20a protects human aortic endothelial cells from Ox-LDL-induced inflammation through targeting TLR4 and TXNIP signaling
Mantian Chen et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Immune cell census in murine atherosclerosis: cytometry by time of flight illuminates vascular myeloid cell diversity
Jennifer E. Cole et al.
CARDIOVASCULAR RESEARCH (2018)
Recent advances on Toll-like receptor 4 modulation: new therapeutic perspectives
Lenny Zaffaroni et al.
FUTURE MEDICINAL CHEMISTRY (2018)
Ablation of toll-like receptor 4 attenuates aging-induced myocardial remodeling and contractile dysfunction through NCoRI-HDAC1-mediated regulation of autophagy
Shuyi Wang et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2018)
The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways
Lu Meng et al.
MOLECULAR IMMUNOLOGY (2018)
Anti-influenza A virus activity of rhein through regulating oxidative stress, TLR4, Akt, MAPK, and NF-κB signal pathways
Qian-Wen Wang et al.
PLOS ONE (2018)
ULINASTATIN PROTECTS AGAINST LPS-INDUCED ACUTE LUNG INJURY BY ATTENUATING TLR4/NF-KB PATHWAY ACTIVATION AND REDUCING INFLAMMATORY MEDIATORS
Chao Cao et al.
SHOCK (2018)
Serum High-Mobility-Group Box 1 as a Biomarker and a Therapeutic Target during Respiratory Virus Infections
Mira C. Patel et al.
MBIO (2018)
MicroRNA-27a alleviates LPS-induced acute lung injury in mice via inhibiting inFLammation and apoptosis through modulating TLR4/MyD88/NF-κB pathway
MinJie Ju et al.
CELL CYCLE (2018)
Toll-like receptor 4 in acute viral infection: Too much of a good thing
Judith Olejnik et al.
PLOS PATHOGENS (2018)
Aflatoxin B-1 Promotes Influenza Replication and Increases Virus Related Lung Damage via Activation of TLR4 Signaling
Yuhang Sun et al.
FRONTIERS IN IMMUNOLOGY (2018)
Exploring immune checkpoints as potential therapeutic targets in atherosclerosis
Pascal J. H. Kusters et al.
CARDIOVASCULAR RESEARCH (2018)
Expression of toll-like receptor 4 and its connection with type 2 diabetes mellitus
Inass M. Taha et al.
CELLULAR AND MOLECULAR BIOLOGY (2018)
Epigallocatechin-3-gallate inhibits TLR4 signaling through the 67-kDa laminin receptor and effectively alleviates acute lung injury induced by H9N2 swine influenza virus
Ming-ju Xu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2017)
LPS enhances TLR4 expression and IFN-γ production via the TLR4/IRAK/NF-κB signaling pathway in rat pulmonary arterial smooth muscle cells
Pengyan Wang et al.
MOLECULAR MEDICINE REPORTS (2017)
Emodin Inhibition of Influenza A Virus Replication and Influenza Viral Pneumonia via the Nrf2, TLR4, p38/JNK and NF-kappaB Pathways
Jian-Ping Dai et al.
MOLECULES (2017)
Inhibition of Toll-Like Receptor Signaling as a Promising Therapy for Inflammatory Diseases: A Journey from Molecular to Nano Therapeutics
Wei Gao et al.
FRONTIERS IN PHYSIOLOGY (2017)
TLR4 Signaling Pathway Modulators as Potential Therapeutics in Inflammation and Sepsis
Nikolay N. Kuzmich et al.
VACCINES (2017)
Obesity and inflammation: the linking mechanism and the complications
Mohammed S. Ellulu et al.
ARCHIVES OF MEDICAL SCIENCE (2017)
TLR2 and TLR4 mediated host immune responses in major infectious diseases: a review
Suprabhat Mukherjee et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2016)
Attenuated Recovery of Contractile Function in Aging Hearts Following Global Ischemia/Reperfusion: Role of Extracellular HSP27 and TLR4
Lihua Ao et al.
MOLECULAR MEDICINE (2016)
Preeclampsia and Diabetes
Tracey L. Weissgerber et al.
CURRENT DIABETES REPORTS (2015)
DAMPs from cell death to new life
Emilie Venereau et al.
FRONTIERS IN IMMUNOLOGY (2015)
Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling
Agnieszka Plociennikowska et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
The Cooperative Roles of Inflammation and Oxidative Stress in the Pathogenesis of Hypertension
Steven D. Crowley
ANTIOXIDANTS & REDOX SIGNALING (2014)
Geroscience: Linking Aging to Chronic Disease
Brian K. Kennedy et al.
CELL (2014)
Modulation of CD14 and TLR4•MD-2 Activities by a Synthetic Lipid A Mimetic
Roberto Cighetti et al.
CHEMBIOCHEM (2014)
Toll-Like Receptor, Lipotoxicity and Chronic inflammation: The Pathological Link Between Obesity and Cardiometabolic Disease
Kosei Eguchi et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2014)
Toll-like Receptor 4 (TLR4) Modulation by Synthetic and Natural Compounds: An Update
Francesco Peri et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis The ACCESS Randomized Trial
Steven M. Opal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Role of the Toll Like Receptor (TLR) Radical Cycle in Chronic Inflammation: Possible Treatments Targeting the TLR4 Pathway
Kurt Lucas et al.
MOLECULAR NEUROBIOLOGY (2013)
Plant-Based Modulation of Toll-like Receptors: An Emerging Therapeutic Model
Dev S. Chahal et al.
PHYTOTHERAPY RESEARCH (2013)
Toll-like receptor 4 contributes to blood pressure regulation and vascular contraction in spontaneously hypertensive rats
Gisele F. Bomfim et al.
CLINICAL SCIENCE (2012)
TLR4 activation of TRPC6-dependent calcium signaling mediates endotoxin-induced lung vascular permeability and inflammation
Mohammad Tauseef et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Protective Role for TLR4 Signaling in Atherosclerosis Progression as Revealed by Infection with a Common Oral Pathogen
Chie Hayashi et al.
JOURNAL OF IMMUNOLOGY (2012)
Elevated expression of the toll like receptors 2 and 4 in obese individuals: its significance for obesity-induced inflammation
Rasheed Ahmad et al.
JOURNAL OF INFLAMMATION-LONDON (2012)
SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon
Allison L. Totura et al.
CURRENT OPINION IN VIROLOGY (2012)
Trial watch FDA-approved Toll-like receptor agonists for cancer therapy
Erika Vacchelli et al.
ONCOIMMUNOLOGY (2012)
Novel interactions of a microbial superantigen with TLR2 and TLR4 differentially regulate IL-17 and Th17-associated cytokines
Hong-Hua Mu et al.
CELLULAR MICROBIOLOGY (2011)
Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studies
Amisha Barochia et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2011)
Blood pressure and renal hemodynamic effects of angiotensin fragments
Rui Yang et al.
HYPERTENSION RESEARCH (2011)
Age-related increases in PGD2 expression impair respiratory DC migration, resulting in diminished T cell responses upon respiratory virus infection in mice
Jincun Zhao et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Intrinsic and Extrinsic Regulation of Innate Immune Receptors
Eunshil Jeong et al.
YONSEI MEDICAL JOURNAL (2011)
Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes
Jin-Kui Yang et al.
ACTA DIABETOLOGICA (2010)
Toll like receptor 4 in atherosclerosis and plaque destabilization
Wijnand K. den Dekker et al.
ATHEROSCLEROSIS (2010)
A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis
Todd W. Rice et al.
CRITICAL CARE MEDICINE (2010)
Increased Toll-Like Receptor (TLR) Activation and TLR Ligands in Recently Diagnosed Type 2 Diabetic Subjects
Mohan R. Dasu et al.
DIABETES CARE (2010)
Toll-like receptor 4 and inducible nitric oxide synthase gene polymorphisms are associated with Type 2 diabetes
Renata A. Bagarolli et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2010)
Targeting Toll-like receptors: emerging therapeutics?
Elizabeth J. Hennessy et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
TLR4 and Insulin Resistance
Jane J. Kim et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2010)
Toll-like receptors in neurodegeneration
Eitan Okun et al.
BRAIN RESEARCH REVIEWS (2009)
Valsartan preconditioning protects against myocardial ischemia-reperfusion injury through TLR4/NF-κB signaling pathway
Jian Yang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2009)
The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex
Beom Seok Park et al.
NATURE (2009)
The aging of the immune system
Daniela Weiskopf et al.
TRANSPLANT INTERNATIONAL (2009)
Identification of oxidative stress and toll-like receptor 4 signaling as a key pathway of acute lung injury
Yumiko Imai et al.
CELL (2008)
Acute modulation of toll-like receptors by insulin
Husam Ghanim et al.
DIABETES CARE (2008)
Fluvastatin reduces increased blood monocyte Toll-like receptor 4 expression in whole blood from patients with chronic heart failure
Gabor Foldes et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2008)
Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors
Kensuke Miyake
SEMINARS IN IMMUNOLOGY (2007)
Immunosenescence: emerging challenges for an ageing population
Danielle Aw et al.
IMMUNOLOGY (2007)
Toll-like receptor 4 in atherosclerosis
Hongli Li et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2007)
Inhibition of homodimerization of Toll-like receptor 4 by curcumin
Hyung S. Youn et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Aging negatively skews macrophage TLR2- and TLR4-mediated pro-inflammatory responses without affecting the IL-2-stimulated pathway
ED Boehmer et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2005)
Statins decrease Toll-like receptor 4 expression and downstream signaling in human CD14+ monocytes
H Methe et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome
CK Wong et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2004)
A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2
SK Wong et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Efficient replication of severe acute respiratory syndrome coronavirus in mouse cells is limited by murine angiotensin-converting enzyme 2
WH Li et al.
JOURNAL OF VIROLOGY (2004)
Respiratory syncytial virus up-regulates TLR4 and sensitizes airway epithelial cells to endotoxin
MM Monick et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study
JSM Peiris et al.
LANCET (2003)
Inhibition of endotoxin response by E5564, a novel toll-like receptor 4-directed endotoxin antagonist
M Mullarkey et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus
EA Kurt-Jones et al.
NATURE IMMUNOLOGY (2000)
Mouse toll-like receptor 4•MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by taxol
K Kawasaki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
